Accurately measure pharmacodynamic protein biomarkers to support decisions in clinical trials.

Data generated in our CLIA certified laboratory can:

• Identify and validate biomarkers
• Monitor drug effects on key pathways
• Guide dose selection
• Aid in measuring efficacy

Testing services are facilitated by a project management team experienced in supporting clinical trials and drug development programs. Myriad RBM’s Multi-Analyte Profile (MAP) and Simoa platforms provide investigators with reliable results that allow discovery, validation, and clinical use of pharmacodynamic biomarkers in a cost-effective, efficient manner.

Myriad RBM provides industry-leading protein biomarker products and services based on our Multi-Analyte Profile (MAP) platform.
Use our products and services to advance your research, drug and diagnostic development projects.

See how other investigators have applied our services for drug development.